White House pulls FDA nominee Heidi Overton after wavering support from
Senate Republicans
[November 18, 2026]
By MATTHEW PERRONE and SEUNG MIN KIM
WASHINGTON (AP) — The White House said Tuesday it has pulled the
nomination of Dr. Heidi Overton to lead the Food and Drug Administration
amid growing indications she didn’t have the votes needed to win Senate
confirmation.
Overton, a physician and White House domestic policy adviser, has spent
most of her professional career working directly for President Donald
Trump or conservative groups aligned with his agenda. Her nomination in
August was seen as a move to bring a stabilizing Trump loyalist to the
FDA, following a tumultuous year under Trump’s first FDA commissioner,
Dr. Marty Makary.
But Overton faced bipartisan questions in the Senate about her
willingness to break from Trump, particularly on his administration's
approach to vaccines.
Republican Sen. Bill Cassidy, a Louisiana doctor who chairs the Senate
health committee, said earlier he remained undecided about Overton ahead
of a critical vote on her nomination scheduled for Wednesday morning.
Cassidy had previously called Overton’s support for Trump’s plan to
break up combination vaccines — including the measles, mumps and rubella
shot — “almost disqualifying.” And he pressed her during a September
hearing about her scientific independence and willingness to disagree
with Trump and Health Secretary Robert F. Kennedy Jr., a longtime
vaccine critic.
But late Tuesday night, Cassidy suggested he had been prepared to back
Overton and suggested her nomination was derailed by disagreements over
abortion, not vaccines.
“I believe she would have had the votes to pass out of committee and
pass the full Senate,” Cassidy stated in a posting on X.

He went on to say that anti-abortion Republicans had sought commitments
on “life issues” from the White House, but “the Administration withdrew
Dr. Overton rather than make such commitments.”
Currently, the FDA is conducting a safety review of the abortion pill
mifepristone — at the request of Trump — that could reinstate
restrictions on the drug’s use, including a requirement for in-person
prescribing. FDA has promised a report on its safety findings by March.
To win confirmation, Overton would have needed the votes of all 12
Republicans on the Senate Health, Education, Labor and Pensions
Committee. Democrats hold 11 seats. Without support of the committee,
Overton faced little chance of winning a full Senate vote on the chamber
floor.
Republicans have been racing to try to confirm Trump’s nominees before
handing over power to Senate Democrats in January.
It was not immediately clear when, or if, the White House might put
forward another nominee.
Cassidy has previously threatened to oppose health nominees
Cassidy has repeatedly tried to win commitments on upholding vaccine
standards, including from Kennedy, by threatening to withhold his vote.
Ultimately, though, he voted in favor of each nominee that came before
his committee.
[to top of second column]
|

Dr. Heidi Overton testifies at the Senate Health, Education,
Labor, and Pensions (HELP) Committee on Capitol Hill, Thursday,
Sept. 24, 2026, in Washington. (AP Photo/Mariam Zuhaib, File)
 Other Republicans, including Maine
Sen. Susan Collins, raised concerns about other health issues,
including Overton's approach to flavored e-cigarettes. The FDA
recently authorized the first fruit-flavored e-cigarettes for adult
smokers looking to quit. Under previous administrations, including
the first Trump administration, the agency had opposed vaping
flavors that could attract teens and children.
Opposition to Overton’s nomination also came from influential
figures in the Make America Healthy Again movement, who blamed her
and other White House officials for sidelining some of Kennedy’s top
health goals, including crackdowns on food additives and pesticides.
Earlier this month, Calley Means told Joe Rogan that White House
aides, including Overton, worked within the administration to
advance a Supreme Court decision blocking thousands of lawsuits over
the weedkiller glyphosate. Means, a former Kennedy aide who recently
left the government, said that and other key decisions were carried
out at the behest of industry lobbyists.
“There is a very concentrated group in the Trump administration that
are antagonistic to what people voted for,” Means said.
Trump has pulled back several other health nominations
Trump’s first nominee for the Centers for Disease Control and
Prevention, Dr. David Weldon, was replaced because it was unclear he
had enough Republican support to be confirmed. Two of Trump’s
surgeon general nominees, including Dr. Casey Means — Calley Means’
sister — were also pulled after facing pushback from Senate
Republicans and most Democrats.
The FDA is currently being led on an acting basis by Kyle Diamantas,
an attorney and friend of Donald Trump Jr. He was elevated to the
post in May after previously serving as the agency’s top food
official. Under federal rules, acting officials are limited to about
seven months leading a federal agency.
The FDA under Makary was marked by a string of scientific disputes,
leadership changes and media stories detailing low morale and
internal dysfunction among staffers. The FDA has lost about 20% of
its employees to layoffs, buyouts, retirements or resignations since
Trump took office.
All contents © copyright 2026 Associated Press. All rights reserved
 |